SEARCH RESULTS FOR:

Mining
Mali
MACIG

Nana Bompeh Sangmuah

PRESIDENT AND CEO, ROSCAN GOLD
Roscan Gold describes progress at its Kandiolé project in Mali.
Mining
Canada

Ruben Padilla

PRESIDENT & CEO, SABLE RESOURCES
Sable Resources explains the potential of its portfolio of resources in Latin America.
Mexico
Petrochemicals & Chemicals

Federico Soto

DIRECTOR GENERAL, ÓRGANO SÍNTESIS
Órgano Síntesis is enjoying a period of rapid expansion to catch up with unprecedented demand.
United States
Pharma & Life Sciences

Chris Garabedian

CHAIRMAN & CEO, XONTOGENY
Xontogeny explains how it can help young companies to cross the valley of death.
Mining
DRC
MACIG

Susa Maleba & Wouter Jordaan

SRK DRC COUNTRY MANAGER & PARTNER AND PRINCIPAL ENVIRONMENTAL SCIENTIST, SRK CONSULTING AFRICA
MACIG Copperbelt & Angola 2021
SRK Consulting describes its services to mining from its DRC office.
Mining
Canada

Roy Slack

DIRECTOR, CEMENTATION AMERICAS
Cementation Americas explains its injection hoisting innovations.
Mining
Canada

Canada, Light at the End of the Tunnel

Rising metals prices and industry resilience have helped miners weather the storm.
Mining
Senegal
Ghana
Burkina Faso
MACIG

Golden Times for The Production Sector?

MACIG West Africa 2020-2021
West Africa mining proves resilient to the pandemic and thrives off the gold revival.
Mining
Canada

Zimi Meka

CO-FOUNDER & CEO, AUSENCO
"We will also be looking to grow our consulting business, in particular in environmental services and we are looking closely at potential acquisitions."
Mining
DRC
MACIG

Nigel Ferguson

MANAGING DIRECTOR, AVZ MINERALS
MACIG Copperbelt & Angola 2021
"A reliable source of power remains challenging in the DRC, therefore, AVZ’s goal is to rely on the use of renewable energy through hydropower at Mpiana Mwanga."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL